Predictive factors for persistent hyperparathyroidism after kidney transplantation

Archives of Iranian Medicine

Volumn 8, Issue 4, 2005, Pages 295-299

  Rangbar Omrani, Gholamhossein ^a   Dabbaghmanesh, Mohammad Hossein ^a   Soleimani, Mohammad ^a   Roozbeh, Jamshid ^b   Raiss Jalali, Ghanbar Ali ^b   Behzadi, Saeid ^b  

^a SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Kidney transplantation; Renal osteodystrophy; Secondary hyperparathyroidism

Indexed keywords

ALBUMIN; CALCIUM; CREATININE; NITROGEN; PARATHYROID HORMONE; PHOSPHATE; UREA;

ADULT; ALBUMIN BLOOD LEVEL; ARTICLE; CALCIUM BLOOD LEVEL; CONTROLLED STUDY; CORRELATION ANALYSIS; CREATININE BLOOD LEVEL; DEMOGRAPHY; DIALYSIS; FEMALE; FOLLOW UP; HUMAN; HYPERCALCEMIA; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PARATHYROID HORMONE BLOOD LEVEL; PHOSPHATE BLOOD LEVEL; POSTOPERATIVE PERIOD; PREDICTION; RISK FACTOR; SECONDARY HYPERPARATHYROIDISM; STATISTICAL SIGNIFICANCE; UREA NITROGEN BLOOD LEVEL;

EID: 27544516272     PISSN: 10292977     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Geis WP, Popovizer MM, Corman JL, et al. The diagnosis and treatment of hyperparathyroidism after renal homotransplantations. Surg Gynecol Obstel. 1973; 137: 997-1010.
2. Kleerekoper M, Ibels LS, Ingham JP, et al. Hyperparathyroidism after renal transplantation. BMJ. 1975; 3: 680-682.
3. Bernheim J, Tourraine JL, David L, et al. Evolution of secondary hyperparathyroidism after renal transplantation. Nephron. 1976; 16: 381-387.
4. Pletka PG, Strom TB, Hampers CL, et al. Secondary hyperparathyroidism in human kidney transplant recipients. Nephron. 1976; 17: 371-381.
5. Favus MJ. Primer on Metabolic Bone Disease and Disorders of Mineral Metabolism. New York, NY: Raven Press; 1993: 159-163.
6. Wolpaw T, Chad LD, Fleming-Brooks S, et al. Factor influencing vertebral bone densitometry after renal transplantation. Transplantation. 1994; 58: 1186.
7. Massari PU. Disorder of bone and mineral metabolism after renal transplantation. Kidney Int. 1997; 52: 1412.
8. Cannata-Andy JB. Renal osteodystrophy: etiology, diagnosis, prevention, and treatment. Kidney Int. 1998; 54: 1000.
9. Almond MK, Kwan JTC, Evans K, et al. Loss of regional bone mineral density in the first 12 months follow-up renal transplantation. Nephron. 1994; 66: 52.
10. Nehme D, Rondeau E, Paillard F, et al. Aseptic necrosis of bone following renal transplantation. Nephrol Dial Transplant. 1989; 4: 123.
11. Payne RB, Carver ME, Morgan DB. Interpretation of serum total calcium: effects of adjustment for albumin concentration on frequency of abnormal values and on detection of change in the individual. J Clin Pathol. 1972; 32: 56-81.
12. Alsina J, Gonzalez MT, Bonnin R, et al. Post-transplantation osteoporosis. Transplant Proc. 1989; 21: 2151.
13. 2+ metabolism after successful renal transplantation. Scand J Urol Nephrol. 1994; 28: 21.
14. Pietschmann P, Vychytil A, Woloszczu K, et al. Pamidronate therapy as prevention of bone loss following renal transplantation. J Nephron. 1991; 59: 533.
15. D' Alessandro AM, Melzer JS, Pirsch JD, et al. Tertiary hyperparathyroidism after renal transplantation. Surgery. 1989; 106: 1049.
16. David DS, Sakal S, Brennan BL. Tertiary hyperparathyroidism. N Engl J Med. 1973; 289: 398.
17. Rosenbaum RW, Hruska KA, Korkor A, Anderson C, Slatopolsky E. Decreased phosphate reabsorption after renal transplantation: evidence for a mechanism independent of calcium and parathyroid hormone. Kidney Int. 1981; 19: 568-578.
18. Parfitt AM, Kleerekoper M, Cruz C. Reduced phosphate reabsorption unrelated to parathyroid hormone after renal transplantation: implications for the pathogenesis of hyperparathyroidism in chronic renal failure. Miner Electrolyte Metab. 1986; 12: 356-362.
19. Reinhardt W, Bartelworth H, Jockenhovel F, et al. Sequential changes of biochemical bone parameters after kidney transplantation. Nephrol Dial Transplant. 1998; 13: 436-442.
20. Higgins RM, Richardson AJ, Endre ZH, Frostick SP, Morris PJ. Hypophosphatemia after renal transplantation: relationship to immunosuppressive drug therapy and effects on muscle detected by 31P nuclear magnetic resonance spectroscopy. Nephrol Dial Transplant. 1990; 5: 62-68.
21. Bilezikian JP, Silverterg SJ, Gartenberg F, et al. Clinical presentation of primary hyperparathyroidism. In: Bilezikian JP, Marcus R, Levine MA, eds. Parathyroids. New York: Raven Press; 1994: 457-470.
22. DeGroot-Leslie J, Jameson-Larry J. Endocrinology, 14th ed. Philadelphia: WB Saunders; 2001: 1075-1092.
23. Gonzales MT, Gonzales C, Grino JM, et al. Long-term evolution of renal osteodystrophy after kidney transplantation: comparative study between intact PTH levels and bone biopsy. Transplant Proc. 1990; 22: 1407-1411.
24. Torres A, Rodriguez AP, Conceptcion MT, et al. Parathyroid function in long-term renal transplant patients: importance of pretransplant PTH concentrations. Nephrol Dial Transplant. 1998; 13 (suppl 3): 94-97.
25. Uda S, Yoshimura A, Sugenoya Y, et al. Role of apoptosis in the progression of secondary hyperparathyroidism. Nippon Jinzo Gakkai Shi. 1996; 38: 323-328.